1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64085E728F72A606C652582CC00375DC7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-gaining-support-patient-adherence-programs-effective-strategies-measuring-effectiveness?opendocument
18
19opendocument
2052.23.234.7
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Patient Advocacy

Gaining Support for Patient Adherence Programs: Effective Strategies and Measuring Effectiveness

ID: 5517


Features:

11 Info Graphics

7 Data Graphics

140+ Metrics

1 Narratives


Pages/Slides: 25


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Gaining Support for Patient Adherence Programs: Effective Strategies and Measuring Effectiveness”

STUDY OVERVIEW

As pharmaceutical and biotechnology companies focus more on improving patient adherence, organizations are searching for ways to boost the effectiveness of their adherence programs. Two hallmarks of successful adherence programs are those with thought out strategies and options and those that measure the effectiveness of their patient adherence programs to drive better outcomes.

Best Practices, LLC undertook this benchmarking research to identify effective tactics and strategies for improving patient adherence. This study also highlights key metrics for measuring adherence program effectiveness, and uses case examples to examine winning approaches for driving adherence.

KEY TOPICS

  • Adherence Programs: Strategic and Tactical Options
  • Measuring Strategy Effectiveness

KEY METRICS

  • Overall, how effective are each of the listed patient adherence activities?
  • In your experience, how effective are each of the listed techniques in improving patient adherence?
  • From your point-of-view, what has been the primary advancement in patient adherence programs over the past several years that has had the most positive impact on improving medication adherence?
  • How important is the use of each type of anonymous and aggregated patient data to the success of your adherence programs?

SAMPLE KEY FINDINGS

  • Different Payer Systems Influence Adherence Approach: US focuses on financial support vs. Europe favors behavioral/quality of life change.

METHODOLOGY


Best Practices, LLC engaged 20 leaders with extensive experience in managing patient adherence operations at 16 leading biopharmaceutical companies.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Alkermes; Amgen; Bayer; Biogen; Celgene; Eisai; Genentech; Janssen; Jazz Pharmaceuticals; LEO Pharma; OTSUKA; Sanofi; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.